No retraction, correction or concern found when last checked on Oct 24, 2026.

C9ORF72: What It Is, What It Does, and Why It Matters

Julie Smeyers, Elena-Gaia Banchi, Morwena Latouche

Frontiers in Cellular Neuroscience · 2021 · Review · CC BY

doi:10.3389/fncel.2021.661447

Abstract

When the non-coding repeat expansion in the C9ORF72 gene was discovered to be the most frequent cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) in 2011, this gene and its derived protein, C9ORF72, were completely unknown. The mutation appeared to produce both haploinsufficiency and gain-of-function effects in the form of aggregating expanded RNAs and dipeptide repeat proteins (DPRs). An unprecedented effort was then unleashed to decipher the pathogenic mechanisms and the functions of C9ORF72 in order to design therapies. A decade later, while the toxicity of accumulating gain-of-function products has been established and therapeutic strategies are being developed to target it, the contribution of the loss of function starts to appear more clearly. This article reviews the current knowledge about the C9ORF72 protein, how it is affected by the repeat expansion in models and patients, and what could be the contribution of its haploinsufficiency to the disease in light of the most recent findings. We suggest that these elements should be taken into consideration to refine future therapeutic strategies, compensating for the decrease of C9ORF72 or at least preventing a further reduction.

References 171

1.
Abo-Rady M. Kalmbach N. Pal A. Schludi C. Janosch A. Richter T. (2020 ). Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 14 390–405.
Not in our library10.1016/j.stemcr.2020.01.010
2.
Al-Sarraj S. King A. Troakes C. Smith B. Maekawa S. Bodi I. (2011 ). p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. (Berl.) 122 691–702.
Not in our library10.1007/s00401-011-0911-2
3.
Amick J. Roczniak-Ferguson A. Ferguson S. M. (2016 ). C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol. Biol. Cell 27 3040–3051.
Not in our library10.1091/mbc.e16-01-0003
4.
Aoki Y. Manzano R. Lee Y. Dafinca R. Aoki M. Douglas A. G. L. (2017 ). C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain J. Neurol. 140 887–897.
Not in our library10.1093/brain/awx024
5.
Arai T. Hasegawa M. Akiyama H. Ikeda K. Nonaka T. Mori H. (2006 ). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 602–611.
Not in our library10.1016/j.bbrc.2006.10.093
6.
Ash P. E. A. Bieniek K. F. Gendron T. F. Caulfield T. Lin W.-L. Dejesus-Hernandez M. (2013 ). Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77 639–646.
Not in our library10.1016/j.neuron.2013.02.004
7.
C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice · 2016
No notice
8.
Atkinson R. A. K. Fernandez-Martos C. M. Atkin J. D. Vickers J. C. King A. E. (2015 ). C9ORF72 expression and cellular localization over mouse development. Acta Neuropathol. Commun. 31 1–11.
Not in our library10.1186/s40478-015-0238-7
9.
Balendra R. Isaacs A. M. (2018 ). C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14 544–558.
Not in our library10.1038/s41582-018-0047-2
10.
Beck J. Poulter M. Hensman D. Rohrer J. D. Mahoney C. J. Adamson G. (2013 ). Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am. J. Hum. Genet. 92 345–353.
Not in our library10.1016/j.ajhg.2013.01.011
11.
Belzil V. V. Bauer P. O. Gendron T. F. Murray M. E. Dickson D. Petrucelli L. (2014 ). Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res. 1584 15–21.
Not in our library10.1016/j.brainres.2014.02.015
12.
Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood · 2013
No notice
13.
Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways · 2016
No notice
14.
Braems E. Swinnen B. Van Den Bosch L. (2020 ). C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta Neuropathol. (Berl.) 140 625–643.
Not in our library10.1007/s00401-020-02214-x
15.
Burberry A. Suzuki N. Wang J.-Y. Moccia R. Mordes D. A. Stewart M. H. (2016 ). Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 8 ra93–ra347.
Not in our library10.1126/scitranslmed.aaf6038
16.
Burberry A. Wells M. F. Limone F. Couto A. Smith K. S. Keaney J. (2020 ). C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582 89–94.
Not in our library10.1038/s41586-020-2288-7
17.
Burrell J. R. Halliday G. M. Kril J. J. Ittner L. M. Götz J. Kiernan M. C. (2016 ). The frontotemporal dementia-motor neuron disease continuum. Lancet 388 919–931.
Not in our library10.1016/s0140-6736(16)00737-6
18.
Chai N. Haney M. S. Couthouis J. Morgens D. W. Benjamin A. Wu K. (2020 ). Genome-wide synthetic lethal CRISPR screen identifies FIS1 as a genetic interactor of ALS-linked C9ORF72. Brain Res. 1728:146601.
Not in our library10.1016/j.brainres.2019.146601
19.
Charcot J.-M. (1869 ). Deux cas d’atrophie musculaire progressive avec lesions de la substance grice et des faisceaux anterolateraux de la moelle epiniere. Arch. Physiol. Norm. Pathol. 354:744.
Not in our library
20.
Chen Y. Lin Z. Chen X. Cao B. Wei Q. Ou R. (2016 ). Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 38 217.e15–217.e22.
Not in our library10.1016/j.neurobiolaging.2015.11.016
21.
Chew J. Gendron T. F. Prudencio M. Sasaguri H. Zhang Y.-J. Castanedes-Casey M. (2015 ). C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348 1151–1154.
Not in our library10.1126/science.aaa9344
22.
A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy · 2018
No notice
23.
Choi S. Y. Lopez-Gonzalez R. Krishnan G. Phillips H. L. Li A. N. Seeley W. W. (2019 ). C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 22 851–862.
Not in our library10.1038/s41593-019-0397-0
24.
Ciura S. Lattante S. Le Ber I. Latouche M. Tostivint H. Brice A. (2013 ). Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 74 180–187.
Not in our library10.1002/ana.23946
25.
Cooper-Knock J. Higginbottom A. Connor-Robson N. Bayatti N. Bury J. J. Kirby J. (2013 ). C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles. Neurology 81 1719–1721.
Not in our library10.1212/01.wnl.0000435295.41974.2e
26.
Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions · 2014
No notice
27.
Davidson Y. S. Robinson A. C. Rollinson S. Pickering-Brown S. Xiao S. Robertson J. (2018 ). Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies. Amyotroph. Lateral Scler. Front. Degener. 19 102–111.
Not in our library10.1080/21678421.2017.1359304
28.
De Franceschi N. Wild K. Schlacht A. Dacks J. B. Sinning I. Filippini F. (2014 ). Longin and GAF domains: structural evolution and adaptation to the subcellular trafficking machinery. Traffic Cph. Den. 15 104–121.
Not in our library10.1111/tra.12124
29.
DeJesus-Hernandez M. Mackenzie I. R. Boeve B. F. Boxer A. L. Baker M. Rutherford N. J. (2011 ). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 245–256.
Not in our library10.1016/j.neuron.2011.09.011
30.
Deng Z. Sheehan P. Chen S. Yue Z. (2017 ). Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease? Mol. Neurodegener. 12:90.
Not in our library10.1186/s13024-017-0232-6
31.
Dickson D. W. Baker M. C. Jackson J. L. DeJesus-Hernandez M. Finch N. A. Tian S. (2019 ). Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. Acta Neuropathol. Commun. 7:150.
Not in our library10.1186/s40478-019-0797-0
32.
Dols-Icardo O. García-Redondo A. Rojas-García R. Sánchez-Valle R. Noguera A. Gómez-Tortosa E. (2014 ). Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum. Mol. Genet. 23 749–754.
Not in our library10.1093/hmg/ddt460
33.
Dong W. Ma Y. Guan F. Zhang X. Chen W. Zhang L. (2020a ). Ablation of C9orf72 together with excitotoxicity induces ALS in rats. FEBS J. 288 1712–1723.
Not in our library10.1111/febs.15501
34.
Dong W. Zhang L. Sun C. Gao X. Guan F. Li J. (2020b ). Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats. Anim. Models Exp. Med. 3 237–244.
Not in our library10.1002/ame2.12129
35.
Donnelly C. J. Zhang P.-W. Pham J. T. Haeusler A. R. Heusler A. R. Mistry N. A. (2013 ). RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80 415–428.
Not in our library10.1016/j.neuron.2013.10.015
36.
Douglas A. G. L. (2018 ). Non-coding RNA in C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunction. Non-Coding RNA Res. 3 178–187.
Not in our library10.1016/j.ncrna.2018.09.001
37.
D’Souza-Schorey C. Chavrier P. (2006 ). ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7 347–358.
Not in our library10.1038/nrm1910
38.
Fang F. Al-Chalabi A. Ronnevi L.-O. Turner M. R. Wirdefeldt K. Kamel F. (2013 ). Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. Amyotroph. Lateral Scler. Front. Degener. 14 362–368.
Not in our library10.3109/21678421.2013.775309
39.
Farg M. A. Sundaramoorthy V. Sultana J. M. Yang S. Atkinson R. A. K. Levina V. (2014 ). C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 23 3579–3595.
Not in our library10.1093/hmg/ddu068
40.
Ferguson R. Serafeimidou-Pouliou E. Subramanian V. (2016 ). Dynamic expression of the mouse ortholog of the human amyotropic lateral sclerosis associated gene C9orf72 during central nervous system development and neuronal differentiation. J. Anat. 229 871–891.
Not in our library10.1111/joa.12526
41.
Flynn K. C. Hellal F. Neukirchen D. Jacob S. Tahirovic S. Dupraz S. (2012 ). ADF/cofilin-mediated actin retrograde flow directs neurite formation in the developing brain. Neuron 76 1091–1107.
Not in our library10.1016/j.neuron.2012.09.038
42.
Fournier C. Barbier M. Camuzat A. Anquetil V. Lattante S. Clot F. (2019 ). Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers. Neurobiol. Aging 74 234.e1–234.e8.
Not in our library10.1016/j.neurobiolaging.2018.09.010
43.
Fratta P. Mizielinska S. Nicoll A. J. Zloh M. Fisher E. M. C. Parkinson G. (2012 ). C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep. 2:1016.
Not in our library10.1038/srep01016
44.
Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia · 2013
No notice
45.
Fredi M. Cavazzana I. Biasiotto G. Filosto M. Padovani A. Monti E. (2019 ). C9orf72 intermediate alleles in patients with amyotrophic lateral sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Neuromolecular. Med. 21 150–159.
Not in our library10.1007/s12017-019-08528-8
46.
Frick P. Sellier C. Mackenzie I. R. A. Cheng C. Y. Tahraoui-Bories J. Martinat C. (2018 ). Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol. Commun. 6:72.
Not in our library10.1186/s40478-018-0579-0
47.
Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS · 2013
No notice
48.
Gendron T. F. Chew J. Stankowski J. N. Hayes L. R. Zhang Y.-J. Prudencio M. (2017 ). Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Sci. Transl. Med. 9:eaai7866.
Not in our library10.1126/scitranslmed.aai7866
49.
Ghasemi M. Keyhanian K. Douthwright C. (2021 ). Glial cell dysfunction in C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia. Cells 10:249.
Not in our library10.3390/cells10020249
50.
Giannandrea M. Bianchi V. Mignogna M. L. Sirri A. Carrabino S. D’Elia E. (2010 ). Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am. J. Hum. Genet. 86 185–195.
Not in our library10.1016/j.ajhg.2010.01.011
51.
Gibson S. B. Abbott D. Farnham J. M. Thai K. K. McLean H. Figueroa K. P. (2016 ). Population-based risks for cancer in patients with ALS. Neurology 87 289–294.
Not in our library10.1212/wnl.0000000000002757
52.
Gijselinck I. Van Langenhove T. van der Zee J. Sleegers K. Philtjens S. Kleinberger G. (2012 ). A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 11 54–65.
Not in our library10.1016/s1474-4422(11)70261-7
53.
Gijselinck I. Van Mossevelde S. van der Zee J. Sieben A. Engelborghs S. De Bleecker J. (2016 ). The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol. Psychiatry 21 1112–1124.
Not in our library10.1038/mp.2015.159
54.
Gonugunta V. K. Sakai T. Pokatayev V. Yang K. Wu J. Dobbs N. (2017 ). Trafficking-mediated STING degradation requires sorting to acidified endolysosomes and can be targeted to enhance anti-tumor response. Cell Rep. 21 3234–3242.
Not in our library10.1016/j.celrep.2017.11.061
55.
Gorno-Tempini M. L. Hillis A. E. Weintraub S. Kertesz A. Mendez M. Cappa S. F. (2011 ). Classification of primary progressive aphasia and its variants. Neurology 76 1006–1014.
Not in our library10.1212/wnl.0b013e31821103e6
56.
Guadagno N. A. Progida C. (2019 ). Rab GTPases: switching to human diseases. Cells 8:909.
Not in our library10.3390/cells8080909
57.
Haeusler A. R. Donnelly C. J. Periz G. Simko E. A. J. Shaw P. G. Kim M. S. (2014 ). C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507 195–200.
Not in our library10.1038/nature13124
58.
Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR · 2019
Not checked
59.
Harms M. B. Cady J. Zaidman C. Cooper P. Bali T. Allred P. (2013 ). Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis. Neurobiol. Aging 34 2234.e13–e19.
Not in our library10.1016/j.neurobiolaging.2013.03.006
60.
Herranz-Martin S. Chandran J. Lewis K. Mulcahy P. Higginbottom A. Walker C. (2017 ). Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits. Dis. Model. Mech. 10 859–868.
Not in our library10.1242/dmm.029892
61.
Huang W. Zhu P. J. Zhang S. Zhou H. Stoica L. Galiano M. (2013 ). MTORC2 controls actin polymerization required for consolidation of long-term memory. Nat. Neurosci. 16 441–448.
Not in our library10.1038/nn.3351
62.
Hübers A. Marroquin N. Schmoll B. Vielhaber S. Just M. Mayer B. (2014 ). Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases. Neurobiol. Aging 35 1214.e1–e6.
Not in our library10.1016/j.neurobiolaging.2013.11.034
63.
Jackson J. L. Finch N. C. A. Baker M. C. Kachergus J. M. Dejesus-Hernandez M. Pereira K. (2020 ). Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers. Mol. Neurodegener. 15:7.
Not in our library10.1186/s13024-020-0359-8
64.
Jewell J. L. Kim Y. C. Russell R. C. Yu F.-X. Park H. W. Plouffe S. W. (2015 ). Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 347 194–198.
Not in our library10.1126/science.1259472
65.
Jiang J. Zhu Q. Gendron T. F. Saberi S. McAlonis-Downes M. Seelman A. (2016 ). Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron 90 535–550.
Not in our library10.1016/j.neuron.2016.04.006
66.
Konno H. Konno K. Barber G. N. (2013 ). Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155 688–698.
Not in our library10.1016/j.cell.2013.09.049
67.
Koppers M. Blokhuis A. M. Westeneng H.-J. Terpstra M. L. Zundel C. A. C. Vieira de Sá R. (2015 ). C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol. 78 426–438.
Not in our library10.1002/ana.24453
68.
LaClair K. D. Zhou Q. Michaelsen M. Wefers B. Brill M. S. Janjic A. (2020 ). Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS. Acta Neuropathol. (Berl.) 140 121–142.
Not in our library10.1007/s00401-020-02176-0
69.
Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72 · 2019
No notice
70.
Lagier-Tourenne C. Baughn M. Rigo F. Sun S. Liu P. Li H.-R. (2013 ). Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U.S.A. 110 E4530–E4539.
Not in our library10.1073/pnas.1318835110
71.
Langseth A. J. Kim J. Ugolino J. E. Shah Y. Hwang H. Y. Wang J. (2017 ). Cell-Type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog. Sci. Rep. 7:5685.
Not in our library10.1038/s41598-017-05864-2
72.
Lappalainen P. Drubin D. G. (1997 ). Cofilin promotes rapid actin filament turnover in vivo. Nature 388 78–82.
Not in our library10.1038/40418
73.
Lawler S. (1999 ). Regulation of actin dynamics: the LIM kinase connection. Curr. Biol. CB 9 R800–R802.
Not in our library10.1016/s0960-9822(99)80493-x
74.
Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic · 2013
Not checked
75.
The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs · 2013
No notice
76.
Lillo P. Hodges J. R. (2009 ). Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas. 16 1131–1135.
Not in our library10.1016/j.jocn.2009.03.005
77.
Ling S.-C. Polymenidou M. Cleveland D. W. (2013 ). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79 416–438.
Not in our library10.1016/j.neuron.2013.07.033
78.
Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function · 2020
Not checked
79.
Liu E. Y. Russ J. Wu K. Neal D. Suh E. McNally A. G. (2014 ). C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol. (Berl.) 128 525–541.
Not in our library10.1007/s00401-014-1286-y
80.
Liu F. Liu Q. Lu C. X. Cui B. Guo X. N. Wang R. R. (2016 ). Identification of a novel loss-of-function C9orf72 splice site mutation in a patient with amyotrophic lateral sclerosis. Neurobiol. Aging 47 219.e1–e5.
Not in our library10.1016/j.neurobiolaging.2016.07.027
81.
Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models · 2021
Not checked
82.
Liu Y. Pattamatta A. Zu T. Reid T. Bardhi O. Borchelt D. R. (2016 ). C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron 90 521–534.
Not in our library10.1016/j.neuron.2016.04.005
83.
Lomen-Hoerth C. Anderson T. Miller B. (2002 ). The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59 1077–1079.
Not in our library10.1212/wnl.59.7.1077
84.
Lomen-Hoerth C. Murphy J. Langmore S. Kramer J. H. Olney R. K. Miller B. (2003 ). Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60 1094–1097.
Not in our library10.1212/01.wnl.0000055861.95202.8d
85.
Lutz C. (2020 ). Realizing the gains and losses in C9ORF72 ALS/FTD. Nat. Neurosci. 23 596–597.
Not in our library10.1038/s41593-020-0622-x
86.
Mackenzie I. R. Arzberger T. Kremmer E. Troost D. Lorenzl S. Mori K. (2013 ). Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. (Berl.) 126 859–879.
Not in our library10.1007/s00401-013-1181-y
87.
Mackenzie I. R. A. Frick P. Grässer F. A. Gendron T. F. Petrucelli L. Cashman N. R. (2015 ). Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. (Berl.) 130 845–861.
Not in our library10.1007/s00401-015-1476-2
88.
Mackenzie I. R. A. Frick P. Neumann M. (2014 ). The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. (Berl.) 127 347–357.
Not in our library10.1007/s00401-013-1232-4
89.
Maharjan N. Künzli C. Buthey K. Saxena S. (2017 ). C9ORF72 regulates stress granule formation and its deficiency impairs stress granule assembly, hypersensitizing cells to stress. Mol. Neurobiol. 54 3062–3077.
Not in our library10.1007/s12035-016-9850-1
90.
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study · 2012
No notice
91.
Malik R. Wiedau M. (2020 ). Therapeutic approaches targeting protein aggregation in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 13:98.
Not in our library10.3389/fnmol.2020.00098
92.
Marat A. L. Dokainish H. McPherson P. S. (2011 ). DENN domain proteins: Regulators of Rab GTPases. J. Biol. Chem. 286 13791–13800.
Not in our library10.1074/jbc.r110.217067
93.
Marie P. (1892 ). Leçons Sur les Maladies de la Moelle. Paris: G. Masson.
Not in our library
94.
McCauley M. E. O’Rourke J. G. Yáñez A. Markman J. L. Ho R. Wang X. (2020 ). C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature 585 96–101.
Not in our library10.1038/s41586-020-2625-x
95.
McGoldrick P. Zhang M. van Blitterswijk M. Sato C. Moreno D. Xiao S. (2018 ). Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression. Neurology 90 e323–e331.
Not in our library10.1212/wnl.0000000000004865
96.
McMillan C. T. Russ J. Wood E. M. Irwin D. J. Grossman M. McCluskey L. (2015 ). C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology 84 1622–1630.
Not in our library10.1212/wnl.0000000000001495
97.
Mignogna M. L. Giannandrea M. Gurgone A. Fanelli F. Raimondi F. Mapelli L. (2015 ). The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition. Nat. Commun. 6 1–15.
Not in our library10.1038/ncomms7504
98.
Miller Z. A. Rankin K. P. Graff-Radford N. R. Takada L. T. Sturm V. E. Cleveland C. M. (2013 ). TDP-43 frontotemporal lobar degeneration and autoimmune disease. J. Neurol. Neurosurg. Psychiatry 84 956–962.
Not in our library10.1136/jnnp-2012-304644
99.
Miller Z. A. Sturm V. E. Camsari G. B. Karydas A. Yokoyama J. S. Grinberg L. T. (2016 ). Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts Completing the picture. Neurol. Neuroimmunol. NeuroInflammation 3:301.
Not in our library10.1212/nxi.0000000000000301
100.
Mitsumoto H. Chad D. A. Pioro E. (1998 ). Amyotrophic Lateral Sclerosis. In Contemporary Neurology Series. Philadelphia, PA: F.A. Davis Company.
Not in our library
101.
C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci · 2013
No notice
102.
Moore K. M. Nicholas J. Grossman M. McMillan C. T. Irwin D. J. Massimo L. (2020 ). Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 19 145–156.
Not in our library10.1016/s1474-4422(19)30394-1
103.
Mordes D. A. Morrison B. M. Ament X. H. Cantrell C. Mok J. Eggan P. (2020 ). Absence of survival and motor deficits in 500 repeat C9ORF72 BAC mice. Neuron 108 775–783.e4.
Not in our library10.1016/j.neuron.2020.08.009
104.
Mori K. Weng S.-M. Arzberger T. May S. Rentzsch K. Kremmer E. (2013 ). The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339 1335–1338.
Not in our library10.1126/science.1232927
105.
Morita M. Al-Chalabi A. Andersen P. M. Hosler B. Sapp P. Englund E. (2006 ). A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66 839–844.
Not in our library10.1212/01.wnl.0000200048.53766.b4
106.
Age-related penetrance of the C9orf72 repeat expansion · 2017
No notice
107.
The Enigmatic Role of C9ORF72 in Autophagy · 2017
Not checked
108.
Neumann M. Sampathu D. M. Kwong L. K. Truax A. C. Micsenyi M. C. Chou T. T. (2006 ). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 130–133.
Not in our library10.1126/science.1134108
109.
Nguyen L. Laboissonniere L. A. Guo S. Pilotto F. Scheidegger O. Oestmann A. (2020 ). Survival and motor phenotypes in FVB C9-500 ALS/FTD BAC transgenic mice reproduced by multiple labs. Neuron 108 784–796.e3.
Not in our library10.1016/j.neuron.2020.09.009
110.
Nordin A. Akimoto C. Wuolikainen A. Alstermark H. Jonsson P. Birve A. (2015 ). Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD. Hum. Mol. Genet. 24 3133–3142.
Not in our library10.1093/hmg/ddv064
111.
O’Rourke J. G. Bogdanik L. Yáñez A. Lall D. Wolf A. J. Muhammad A. K. M. G. (2016 ). C9orf72 is required for proper macrophage and microglial function in mice. Science 351 1324–1329.
Not in our library10.1126/science.aaf1064
112.
Pamphlett R. Cheong P. L. Trent R. J. Yu B. (2013 ). Can ALS-associated C9orf72 repeat expansions be diagnosed on a blood DNA test alone? PLoS One 8:e70007.
Not in our library10.1371/journal.pone.0070007
113.
Peters O. M. Cabrera G. T. Tran H. Gendron T. F. McKeon J. E. Metterville J. (2015 ). Human C9ORF72 hexanucleotide expansion reproduces RNA Foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice. Neuron 88 902–909.
Not in our library10.1016/j.neuron.2015.11.018
114.
Prabakaran T. Bodda C. Krapp C. Zhang B.-C. Christensen M. H. Sun C. (2018 ). Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1. EMBO J. 37:e97858.
Not in our library10.15252/embj.201797858
115.
Rangaraju V. Lauterbach M. Schuman E. M. (2019 ). Spatially stable mitochondrial compartments fuel local translation during plasticity. Cell 176 73–84.e15.
Not in our library10.1016/j.cell.2018.12.013
116.
Rascovsky K. Hodges J. R. Knopman D. Mendez M. F. Kramer J. H. Neuhaus J. (2011 ). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain J. Neurol. 134 2456–2477.
Not in our library10.1093/brain/awr179
117.
Reddy K. Zamiri B. Stanley S. Y. R. Macgregor R. B. Pearson C. E. (2013 ). The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem. 288 9860–9866.
Not in our library10.1074/jbc.c113.452532
118.
Renton A. E. Majounie E. Waite A. Simón-Sánchez J. Rollinson S. Gibbs J. R. (2011 ). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72 257–268.
Not in our library10.1016/j.neuron.2011.09.010
119.
Rizzu P. Blauwendraat C. Heetveld S. Lynes E. M. Castillo-Lizardo M. Dhingra A. (2016 ). C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. Acta Neuropathol. Commun. 4:37.
Not in our library10.1186/s40478-016-0306-7
120.
Russ J. Liu E. Y. Wu K. Neal D. Suh E. Irwin D. J. (2015 ). Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. (Berl.) 129 39–52.
Not in our library10.1007/s00401-014-1365-0
121.
Saberi S. Stauffer J. E. Jiang J. Garcia S. D. Taylor A. E. Schulte D. (2018 ). Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 135 459–474.
Not in our library10.1007/s00401-017-1793-8
122.
Sareen D. O’Rourke J. G. Meera P. Muhammad A. K. M. G. Grant S. Simpkinson M. (2013 ). Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 5:208ra149.
Not in our library10.1126/scitranslmed.3007529
123.
Schludi M. H. Becker L. Garrett L. Gendron T. F. Zhou Q. Schreiber F. (2017 ). Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. (Berl.) 134 241–254.
Not in our library10.1007/s00401-017-1711-0
124.
Sellier C. Campanari M.-L. Julie Corbier C. Gaucherot A. Kolb-Cheynel I. Oulad-Abdelghani M. (2016 ). Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 35 1276–1297.
Not in our library10.15252/embj.201593350
125.
C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity · 2018
No notice
126.
Shao Q. Liang C. Chang Q. Zhang W. Yang M. Chen J.-F. (2019 ). C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta Neuropathol. Commun. 7:32.
Not in our library10.1186/s40478-019-0685-7
127.
Shao Q. Yang M. Liang C. Ma L. Zhang W. Jiang Z. (2020 ). C9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy 16 1635–1650.
Not in our library10.1080/15548627.2019.1703353
128.
Shi M. Shi C. Xu Y. (2017 ). Rab GTPases: the key players in the molecular pathway of Parkinson’s disease. Front. Cell. Neurosci. 11:81.
Not in our library10.3389/fncel.2017.00081
129.
Shi Y. Lin S. Staats K. A. Li Y. Chang W.-H. Hung S.-T. (2018 ). Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 24 313–325.
Not in our library10.1038/nm.4490
130.
Sivadasan R. Hornburg D. Drepper C. Frank N. Jablonka S. Hansel A. (2016 ). C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nat. Neurosci. 19 1610–1618.
Not in our library10.1038/nn.4407
131.
Stamatakou E. Wróbel L. Hill S. M. Puri C. Son S. M. Fujimaki M. (2020 ). Mendelian neurodegenerative disease genes involved in autophagy. Cell Discov. 6:24.
Not in our library10.1038/s41421-020-0158-y
132.
Starr A. Sattler R. (2018 ). Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD. Brain Res. 1693 98–108.
Not in our library10.1016/j.brainres.2018.02.011
133.
Su M. Y. Fromm S. A. Zoncu R. Hurley J. H. (2020 ). Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD. Nature 585 251–255.
Not in our library10.1038/s41586-020-2633-x
134.
Su Z. Zhang Y. Gendron T. F. Bauer P. O. Chew J. Yang W. Y. (2014 ). Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Neuron 83 1043–1050.
Not in our library10.1016/j.neuron.2014.07.041
135.
Sudria-Lopez E. Koppers M. de Wit M. van der Meer C. Westeneng H.-J. Zundel C. A. C. (2016 ). Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. (Berl.) 132 145–147.
Not in our library10.1007/s00401-016-1581-x
136.
Suh E. Lee E. B. Neal D. Wood E. M. Toledo J. B. Rennert L. (2015 ). Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration. Acta Neuropathol. (Berl.) 130 363–372.
Not in our library10.1007/s00401-015-1445-9
137.
The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway · 2016
No notice
138.
Suzuki N. Maroof A. M. Merkle F. T. Koszka K. Intoh A. Armstrong I. (2013 ). The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD. Nat. Neurosci. 16 1725–1727.
Not in our library10.1038/nn.3566
139.
Sztul E. Chen P.-W. Casanova J. E. Cherfils J. Dacks J. B. Lambright D. G. (2019 ). ARF GTPases and their GEFs and GAPs: concepts and challenges. Mol. Biol. Cell 30 1249–1271.
Not in our library10.1091/mbc.e18-12-0820
140.
Tang B. L. (2016 ). C9orf72’s interaction with Rab GTPases—modulation of membrane traffic and autophagy. Front. Cell. Neurosci. 10:228.
Not in our library10.3389/fncel.2016.00228
141.
Tang D. Sheng J. Xu L. Yan C. Qi S. (2020a ). The C9orf72-SMCR8-WDR41 complex is a GAP for small GTPases. Autophagy 16 1542–1543.
Not in our library10.1080/15548627.2020.1779473
142.
Tang D. Sheng J. Xu L. Zhan X. Liu J. Jiang H. (2020b ). Cryo-EM structure of C9ORF72–SMCR8–WDR41 reveals the role as a GAP for Rab8a and Rab11a. Proc. Natl. Acad. Sci. U.S.A. 117 9876–9883.
Not in our library10.1073/pnas.2002110117
143.
Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans · 2013
No notice
144.
Tran H. Almeida S. Moore J. Gendron T. F. Chalasani U. Lu Y. (2015 ). Differential toxicity of nuclear RNA Foci versus dipeptide repeat proteins in a Drosophila model of C9ORF72 FTD/ALS. Neuron 87 1207–1214.
Not in our library10.1016/j.neuron.2015.09.015
145.
Turner M. R. Goldacre R. Ramagopalan S. Talbot K. Goldacre M. J. (2013 ). Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81 1222–1225.
Not in our library10.1212/wnl.0b013e3182a6cc13
146.
Loss of C9orf72 Enhances Autophagic Activity via Deregulated mTOR and TFEB Signaling · 2016
No notice
147.
van Blitterswijk M. DeJesus-Hernandez M. Niemantsverdriet E. Murray M. E. Heckman M. G. Diehl N. N. (2013 ). Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study. Lancet Neurol. 12 978–988.
Not in our library10.1016/s1474-4422(13)70210-2
148.
van Blitterswijk M. DeJesus-Hernandez M. Rademakers R. (2012 ). How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr. Opin. Neurol. 25 689–700.
Not in our library10.1097/wco.0b013e32835a3efb
149.
van Blitterswijk M. Gendron T. F. Baker M. C. DeJesus-Hernandez M. Finch N. A. Brown P. H. (2015 ). Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72. Acta Neuropathol. (Berl.) 130 863–876.
Not in our library10.1007/s00401-015-1480-6
150.
A Pan‐ E uropean Study of the C9orf72 Repeat Associated with FTLD : Geographic Prevalence, Genomic Instability, and Intermediate Repeats · 2013
No notice
151.
Van Mossevelde S. van der Zee J. Cruts M. Van Broeckhoven C. (2017a ). Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev. 44 117–124.
Not in our library10.1016/j.gde.2017.02.008
152.
Van Mossevelde S. van der Zee J. Gijselinck I. Sleegers K. De Bleecker J. Sieben A. (2017b ). Clinical evidence of disease anticipation in families segregating a C9orf72 repeat expansion. JAMA Neurol. 74 445–452.
Not in our library10.1001/jamaneurol.2016.4847
153.
Vance C. Al-Chalabi A. Ruddy D. Smith B. N. Hu X. Sreedharan J. (2006 ). Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain J. Neurol. 129 868–876.
Not in our library10.1093/brain/awl030
154.
Viodé A. Fournier C. Camuzat A. Fenaille F., NeuroCEB Brain Bank, Latouche M. (2018 ). New antibody-free mass spectrometry-based quantification reveals that C9ORF72 long protein isoform is reduced in the frontal cortex of hexanucleotide-repeat expansion carriers. Front. Neurosci. 12:589.
Not in our library10.3389/fnins.2018.00589
155.
Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion · 2014
No notice
156.
Wang M. Wang H. Tao Z. Xia Q. Hao Z. Prehn J. H. M. (2020 ). C9orf72 associates with inactive Rag GTPases and regulates mTORC1-mediated autophagosomal and lysosomal biogenesis. Aging Cell 19:e13126.
Not in our library10.1111/acel.13126
157.
Wang T. Liu H. Itoh K. Oh S. Zhao L. Murata D. (2021 ). C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab. 33 531–546.e9.
Not in our library10.1016/j.cmet.2021.01.005
158.
The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy · 2016
No notice
159.
Xi Z. Rainero I. Rubino E. Pinessi L. Bruni A. C. Maletta R. G. (2014 ). Hypermethylation of the CpG-island near the C9orf72 G4C2-repeat expansion in FTLD patients. Hum. Mol. Genet. 23 5630–5637.
Not in our library10.1093/hmg/ddu279
160.
Xi Z. Zhang M. Bruni A. C. Maletta R. G. Colao R. Fratta P. (2015 ). The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. (Berl.) 129 715–727.
Not in our library10.1007/s00401-015-1401-8
161.
Xiao S. MacNair L. McGoldrick P. McKeever P. M. McLean J. R. Zhang M. (2015 ). Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann. Neurol. 78 568–583.
Not in our library10.1002/ana.24469
162.
Xiao S. MacNair L. McLean J. McGoldrick P. McKeever P. Soleimani S. (2016 ). C9orf72 isoforms in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Brain Res. 1647 43–49.
Not in our library10.1016/j.brainres.2016.04.062
163.
Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels · 2019
Not checked
164.
Yang M. Chen L. Swaminathan K. Herrlinger S. Lai F. Shiekhattar R. (2016 ). A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2:e1601167.
Not in our library10.1126/sciadv.1601167
165.
Yoshimura S. I. Gerondopoulos A. Linford A. Rigden D. J. Barr F. A. (2010 ). Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. J. Cell Biol. 191 367–381.
Not in our library10.1083/jcb.201008051
166.
Discovery of Novel DENN Proteins: Implications for the Evolution of Eukaryotic Intracellular Membrane Structures and Human Disease · 2012
No notice
167.
Zhang M. Tartaglia M. C. Moreno D. Sato C. McKeever P. Weichert A. (2017 ). DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients. Acta Neuropathol. (Berl.) 134 271–279.
Not in our library10.1007/s00401-017-1713-y
168.
Zhang Y. Burberry A. Wang J. Y. Sandoe J. Ghosh S. Udeshi N. D. (2018 ). The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 32 929–943.
Not in our library10.1101/gad.313932.118
169.
Zhang Y.-J. Gendron T. F. Grima J. C. Sasaguri H. Jansen-West K. Xu Y.-F. (2016 ). C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat. Neurosci. 19 668–677.
Not in our library10.1038/nn.4272
170.
Zhu Q. Jiang J. Gendron T. F. McAlonis-Downes M. Jiang L. Taylor A. (2020 ). Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci. 23 615–624.
Not in our library10.1038/s41593-020-0619-5
171.
Zu T. Liu Y. Bañez-Coronel M. Reid T. Pletnikova O. Lewis J. (2013 ). RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 110 E4968–E4977.
Not in our library10.1073/pnas.1315438110

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.